NCT07242482Not yet recruiting
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
Study on the Clinical Value of Circulating Immune Markers in Prognostic Evaluation of Postoperative Lung Cancer Patients
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
Investigating the Clinical Value of Tumor Antigen-Specific T Cells and Immune Cell Balance in Peripheral Blood of Non-Small Cell Lung Cancer Patients for Prognostic Evaluation.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 17 Dec 2025
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Zhao Jun
- Diseases
- Lung cancer
- NCT number
- NCT07242482
What you commit to
- Study type: Observational
- Planned participants: 200
- From 17 Dec 2025 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received any neoadjuvant therapy prior to surgery.
Other illness
- History of other active malignancies.
- Diagnosed with severe autoimmune diseases, active infections, or immunodeficiency disorders.
- Presence of severe cardiac, hepatic, or renal dysfunction.
Other
- Pregnant or lactating women.
Who the study is looking for
- Age 18 to 80 years.
- Diagnosed with primary non-small cell lung cancer (NSCLC) and scheduled to undergo curative lung resection at the Department of Thoracic Surgery of our institution.
- Postoperative pathological stage is IB (with tumor size \>4cm or high-risk factors: poor differentiation, vascular invasion, visceral pleural invasion, sub-lobar resection, etc.), IIA, IIB, or IIIB (according to the AJCC 8th edition).
- ECOG performance status of 0 or 1.
- Voluntarily signs the informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Soochow university, Suzhou, Jiangsu 215000 Coordinator of this site? Confirm its status | Suzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.